Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Maziar Mike Doustdar
Pharma
Novo's Wegovy pill debuts with $355M in Q1
After several quarters on the backfoot, Danish drug juggernaut Novo Nordisk is receiving warmer feedback on its starting performance in 2026.
Fraiser Kansteiner
May 6, 2026 11:21am
Novo eyes Ireland expansion for ex-US Wegovy pill supply: report
Feb 12, 2026 3:15pm
Fierce Biotech
Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera
Nov 7, 2025 10:00am
Novo's new CEO Doustdar lays out ambitions after shaky Q3
Nov 5, 2025 11:14am
Novo plots board shake-up after stalemate in leadership talks
Oct 21, 2025 11:36am
Novo Nordisk tells employees they must return to office Jan. 1
Sep 11, 2025 2:13pm
